Patient Safety and Infusion Management: Rethinking the Role of Filtration

Recorded On: 11/04/2014

With the critical need to ensure safe and proper administration of infusion therapy, it is more important than ever to assess the role filtration can play in reducing the risks associated with particle and bacterial contamination, and drug incompatibility reactions. This timely webinar will present scientific evidence of how intravenous (IV) filtration can be used as a preventive strategy to reduce infusion therapy-related complication rate.

image

Marcia Ryder, PhD, MS, RN

Dr. Marcia Ryder's extensive experience in nursing includes positions as a clinical director of a special care unit and a cardiovascular/thoracic unit, a clinical nurse specialist in nutrition support, and a director of nursing in home infusion. Dr. Ryder received a nursing diploma from the Western Pennsylvania Hospital School of Nursing in Pittsburgh and her bachelor’s, master’s, and doctoral degrees from the University of California, San Francisco. She is currently an independent collaborative researcher and consultant in medical biofilm related infections, where her research includes in vitro, in vivo, and clinical investigations. Dr. Ryder is also a nationally and internationally recognized expert in the use and management of vascular access devices, and has been an invited speaker to state, national, and international conferences and has authored numerous publications. She has served as President of AVA, Chair of APIC’s Scientific Research Council, and President of the AVA Foundation for Patient Safety, and was the recipient of the 2017 Suzanne Herbst Award for Excellence in Vascular Access awarded by AVA. Dr. Ryder is currently the president of the Vascular Access Patient Safety Alliance (VAPSA), a distinguished fellow of the National Academies of Practice, and a National Quality Forum Hospital-Onset Bacteremia and Fungemia Technical Expert Panelist.

Thomas Jack, MD

Pediatric Intensive Care Unit (PICU) of the Hannover Medical School

Dr. Thomas Jack graduated from Phillips University Marburg in 1998 and the Hannover Medical School in 2002. Before his career in Pediatrics, he worked in the research department of CYTONET, a biotechnological company associated with the Hannover Medical School. His focus was the development of new molecular genetics-based diagnostic kits for different infections. In 2005, he obtained his MD and joined the Department of Pediatric Cardiology and Intensive Care Medicine at the Hannover Medical School in 2003. In 2012 he began work as a consultant pediatric intensivist for the Pediatric Intensive Care Unit (PICU) of the Hannover Medical School. His major field of clinical research is the management of infusion therapy, patient safety in the PICU, and inflammation/coagulation of critically ill children. He has published several articles in the field of IV therapy and in-line filtration. He published his first clinical study in 2012, which proved the positive benefits of in-line filtration on the outcome of intensive care patients. Together with the members of the working group for infusion management at the Hannover Medical School, he led the development of a new workshop concept for infusion management on the ICU/PICU.

This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: November 4, 2016

This session has been approved for 1 CRNI® recertification unit
There is no expiration date for receipt of CRNI® recertification unit

  • Registration Closed

Key:

Complete
Failed
Available
Locked
Online Archive
Evaluation
Please take a few minutes to complete an evaluation of the session You must register to access.
Certificate
Printable Certificate You must register to access.